The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells

Author: Kim M.   Zinn K.R.   Barnett B.G.   Sumerel L.A.   Krasnykh V.   Curiel D.T.   Douglas J.T.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.38, Iss.14, 2002-09, pp. : 1917-1926

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content